Tech Company Financing Transactions
Accu-Break Pharmaceuticals Funding Round
On 6/4/2007, Accu-Break Pharmaceuticals received $5.7 million in funding from FirstMark Capital and SAC Capital.
Transaction Overview
Company Name
Announced On
6/4/2007
Transaction Type
Venture Equity
Amount
$5,650,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6100 Hollywood Blvd. 307
Hollywood, FL 33024
USA
Hollywood, FL 33024
USA
Phone
Email Address
Overview
Accu-Break develops pharmaceutical tablet technologies to create tablets that can be easily divided by hand into exact smaller doses.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Elliot Hahn
Co-Founder
David Lucking
President
Robert Goldfarb
Browse more venture capital transactions:
Prev: 6/4/2007: Tumri venture capital transaction
Next: 6/4/2007: Innovative Metabolics venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs